{"meta":{"query_hash":"55e85dd4d3d6","filters":{"venue":"Oncology and Therapy"},"cohort_total":22,"direct_labels_cover":0,"predictions_cover":22,"exported":22,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/55e85dd4d3d6","api":"https://metacan.xera.ac/api/v1/cohort?venue=Oncology+and+Therapy"},"results":[{"id":"W2526572293","doi":"10.1007/s40487-016-0030-2","title":"Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma","year":2016,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dabrafenib; Trametinib; Vemurafenib; Ipilimumab; Medicine; Dacarbazine; Internal medicine; Oncology; Hazard ratio; Progression-free survival; Melanoma; Confidence interval; Metastatic melanoma; Cancer research; Chemotherapy; Cancer; Biology; Immunotherapy; MAPK/ERK pathway","score_opus":0.05188755218340509,"score_gpt":0.320069913384466,"score_spread":0.2681823612010609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526572293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98957324,0.008581823,0.000539874,0.00047942623,0.0000626553,0.0002484467,0.00012741111,0.0000027318208,0.00038436253],"genre_scores_gemma":[0.9954143,0.003603513,0.0006299228,0.000044111417,0.000037955135,0.00004792492,0.00006750094,0.000008196519,0.00014658703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896705,0.00026844576,0.0002818507,0.00025437525,0.00008095677,0.00014734016],"domain_scores_gemma":[0.99922425,0.00027203307,0.00018289634,0.00021790525,0.00005660464,0.000046314868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029819814,0.0001442833,0.0007274847,0.00007142033,0.000034545963,0.0000029472767,0.00007119347,0.000108376415,0.0000564119],"category_scores_gemma":[0.000025728237,0.000083452294,0.00018107524,0.00010665441,0.00013843477,0.0000046590085,0.000033245793,0.000021809909,2.3049148e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01020266,0.00468784,0.25006488,0.00008548587,0.24272929,0.00023777461,0.0021871212,0.00046807635,0.2292728,0.018166462,0.00021771657,0.2416799],"study_design_scores_gemma":[0.04930663,0.067469425,0.49043503,0.000056796594,0.072838515,0.000095339405,0.00047626052,0.00039548043,0.27541396,0.021809725,0.0200819,0.0016209253],"about_ca_topic_score_codex":0.000081861355,"about_ca_topic_score_gemma":0.0009295553,"teacher_disagreement_score":0.24037015,"about_ca_system_score_codex":0.000009770393,"about_ca_system_score_gemma":0.000049185142,"threshold_uncertainty_score":0.34030858},"labels":[],"label_agreement":null},{"id":"W2793685398","doi":"10.1007/s40487-018-0056-8","title":"Uveal Melanoma: A Review of the Literature","year":2018,"lang":"en","type":"review","venue":"Oncology and Therapy","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Melanoma; Medicine; Enucleation; Uvea; Metastasis; Dermatology; Disease; Ocular Melanoma; Pathology; Cancer; Internal medicine; Surgery; Cancer research","score_opus":0.039370848623730095,"score_gpt":0.39129297175629807,"score_spread":0.351922123132568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793685398","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033959415,0.99190193,1.6224553e-7,0.0005780988,0.00038226388,0.0011755439,0.000024376764,0.000010930237,0.005892748],"genre_scores_gemma":[0.0000069193434,0.99613523,0.00007751188,0.0018118403,0.00022332263,0.00009322099,0.000070319176,0.000020511228,0.0015611211],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986911,0.0004425802,0.00036747204,0.00025900392,0.0000892657,0.00015057185],"domain_scores_gemma":[0.99894524,0.0001442413,0.00034717328,0.00042504273,0.00008056062,0.000057766472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031479393,0.00025688493,0.0017923795,0.000052817002,0.00007934846,0.0000026655014,0.00013147948,0.0007086678,0.00017557052],"category_scores_gemma":[0.00004364943,0.00011885783,0.00048958947,0.0002345726,0.00031513567,0.000016925189,0.00004662749,0.00044153183,0.000028331262],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004875323,0.00024428716,0.000089496025,0.034845114,0.0008548224,0.00008642478,0.00006121754,4.7502578e-11,1.2933927e-7,0.00017868563,0.0036283887,0.95996267],"study_design_scores_gemma":[0.00086694385,0.001234373,0.000059378093,0.09149606,0.0013662328,0.0010816739,0.0000012690599,1.2087381e-8,0.0000015172117,0.00008843196,0.9037274,0.00007669882],"about_ca_topic_score_codex":0.0000013286962,"about_ca_topic_score_gemma":0.0000015243675,"teacher_disagreement_score":0.95988595,"about_ca_system_score_codex":0.00005604267,"about_ca_system_score_gemma":0.000537498,"threshold_uncertainty_score":0.5465895},"labels":[],"label_agreement":null},{"id":"W2896198794","doi":"10.1007/s40487-018-0065-7","title":"Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","year":2018,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"Cancer survivorship and care","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"Common Terminology Criteria for Adverse Events; Medicine; Documentation; Adverse effect; MEDLINE; Ambulatory; Patient satisfaction; Family medicine; Surgery; Internal medicine","score_opus":0.03526889379340401,"score_gpt":0.35689994923705654,"score_spread":0.3216310554436525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896198794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729496,0.0002822876,0.0000067909396,0.00082935544,0.0007918118,0.0006387225,0.00004112047,0.0000055570367,0.00010942015],"genre_scores_gemma":[0.9984385,0.00030228778,0.000028042716,0.0010811402,0.000047348753,0.000032372303,0.000007776288,0.000011162004,0.000051384726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913514,0.00013954223,0.00031972033,0.00014641605,0.00010495899,0.0001542113],"domain_scores_gemma":[0.99917865,0.00013314949,0.00029102116,0.00021334858,0.00016345452,0.000020382618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019985173,0.00011143765,0.00038229246,0.00004629311,0.00007646735,9.3125664e-7,0.00009034101,0.00012131115,0.00006769133],"category_scores_gemma":[0.00002584058,0.000062834355,0.00008223083,0.00010934059,0.00031120217,0.000028620194,0.000030748073,0.00008355595,1.01295804e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024512727,0.00024144369,0.97020084,0.000028538068,0.000094296636,5.96967e-7,0.0037615187,6.360188e-7,0.003915557,0.000015808819,0.000056129174,0.019233376],"study_design_scores_gemma":[0.0060865167,0.0016814573,0.9742727,0.0000712105,0.000025800093,0.000004084238,0.00069446466,0.00007400997,0.013684971,0.00014637437,0.0031827844,0.00007560421],"about_ca_topic_score_codex":0.0012342981,"about_ca_topic_score_gemma":0.002066683,"teacher_disagreement_score":0.019157771,"about_ca_system_score_codex":0.000068346075,"about_ca_system_score_gemma":0.00009908813,"threshold_uncertainty_score":0.25623107},"labels":[],"label_agreement":null},{"id":"W2911783086","doi":"10.1007/s40487-019-0093-y","title":"Correction to: Uveal Melanoma: A Review of the Literature","year":2019,"lang":"en","type":"review","venue":"Oncology and Therapy","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Melanoma; Information retrieval; Computer science; Medicine; History; Cancer research","score_opus":0.03696998735483649,"score_gpt":0.38780590185358327,"score_spread":0.3508359144987468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911783086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031184412,0.9895334,5.530092e-7,0.00058918906,0.0021307943,0.0018411485,0.000015326463,0.000010738409,0.0058476543],"genre_scores_gemma":[0.000015085907,0.99143726,0.0000384333,0.002333268,0.00013090609,0.000109561064,0.000064798835,0.000019100993,0.005851605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988413,0.00036807836,0.00031599906,0.00025591478,0.000085826905,0.0001329011],"domain_scores_gemma":[0.99902976,0.00021937356,0.00026148287,0.00036398132,0.00006715365,0.000058240727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024637868,0.00022895604,0.0016623794,0.00006907229,0.00005502768,0.0000028554352,0.00009783031,0.00047912353,0.00010317418],"category_scores_gemma":[0.00006492832,0.000113965085,0.00040371026,0.000288032,0.00007296469,0.000016642873,0.000037639773,0.00049737195,0.000051990595],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006634727,0.00018264476,0.00013285031,0.021194167,0.00048715904,0.00003104724,0.000064812,2.1157527e-9,3.8583588e-7,0.000050718536,0.008499405,0.96929044],"study_design_scores_gemma":[0.0006865022,0.0014530494,0.00015183544,0.094987,0.0011413652,0.0007903893,0.000002050114,6.2438424e-8,0.0000018500958,0.000012880194,0.9006968,0.00007619101],"about_ca_topic_score_codex":0.000003378524,"about_ca_topic_score_gemma":0.0000030824212,"teacher_disagreement_score":0.96921426,"about_ca_system_score_codex":0.000089892616,"about_ca_system_score_gemma":0.00050180714,"threshold_uncertainty_score":0.46473613},"labels":[],"label_agreement":null},{"id":"W3124101675","doi":"10.1007/s40487-020-00135-z","title":"Recent Advances in the Management of Penile Cancer: A Contemporary Review of the Literature","year":2021,"lang":"en","type":"review","venue":"Oncology and Therapy","topic":"Genital Health and Disease","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Penile cancer; Medicine; Disease; Intensive care medicine; Multidisciplinary approach; Human papilloma virus; Cancer; Clinical trial; Internal medicine; Cervical cancer","score_opus":0.06502141781225386,"score_gpt":0.44325937406545457,"score_spread":0.3782379562532007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124101675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016788135,0.98926014,3.753006e-8,0.001691308,0.00016486949,0.0017102467,0.000047684214,0.0000018795532,0.007107054],"genre_scores_gemma":[0.000086261025,0.9958608,0.000012736247,0.0034319127,0.00004236823,0.00030277218,0.000060171787,0.000006957522,0.00019600443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875855,0.0004342471,0.00043001337,0.000156443,0.000119609984,0.00010111716],"domain_scores_gemma":[0.999203,0.000101126614,0.00030027737,0.00028609578,0.000065501226,0.000043981883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003837012,0.0001373913,0.0010706628,0.000030704658,0.000025935557,0.0000017666405,0.00012879634,0.00012159839,0.000096956996],"category_scores_gemma":[0.000011598096,0.000059798116,0.00019497219,0.000367465,0.00007810696,0.000018674482,0.000026627382,0.00026312505,4.8307754e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061419894,0.00015437717,0.000032252996,0.17509878,0.000037776943,0.00005032063,0.00009165156,3.083921e-9,1.5222783e-8,0.0001910439,0.0012472527,0.8230351],"study_design_scores_gemma":[0.00054386666,0.00018159446,0.00006870792,0.10538671,0.00023675481,0.000036471993,0.000059290287,1.8594614e-8,1.9195568e-7,0.000041274594,0.8934041,0.000041003696],"about_ca_topic_score_codex":0.0000041232443,"about_ca_topic_score_gemma":0.000004743528,"teacher_disagreement_score":0.89215684,"about_ca_system_score_codex":0.000029398705,"about_ca_system_score_gemma":0.0007493902,"threshold_uncertainty_score":0.24384965},"labels":[],"label_agreement":null},{"id":"W4214763123","doi":"10.1007/s40487-022-00187-3","title":"Estimating the Impact of Delayed Access to Oncology Drugs on Patient Outcomes in Canada","year":2022,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada); University of Calgary","funders":"Parexel; Amgen","keywords":"Reimbursement; Medicine; Context (archaeology); Lung cancer; Medical prescription; Family medicine; Health care; Oncology; Geography; Economic growth; Pharmacology; Economics","score_opus":0.23925194046491302,"score_gpt":0.47329611718186954,"score_spread":0.23404417671695651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214763123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96242493,0.00036360105,0.000033988195,0.033881962,0.0004990604,0.00059455045,0.00016419191,0.000004873545,0.002032852],"genre_scores_gemma":[0.9746561,0.000039388484,0.00022562635,0.024761705,0.000028519107,0.00024375787,0.000006868364,0.00001038501,0.000027656995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975259,0.00045893155,0.001465438,0.00025175922,0.0000562343,0.00024173997],"domain_scores_gemma":[0.9968836,0.0018275449,0.00096624874,0.00022760505,0.000018126562,0.00007691358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045215953,0.00010914119,0.00069804647,0.00016218405,0.0002044455,0.000010285335,0.0002674754,0.000049453156,0.00047032235],"category_scores_gemma":[0.00032343835,0.000095132134,0.000055823304,0.00015431897,0.000033084423,0.00007102102,0.00008756681,0.0002171737,0.0000122783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005928505,0.00060698047,0.81815547,0.000020290798,0.00030489184,0.000009387525,0.01988208,0.073152326,0.0000049034634,0.011560682,0.0246355,0.051074646],"study_design_scores_gemma":[0.0048410567,0.0072911023,0.8438801,0.000020296135,0.0000054747707,0.000019528532,0.007196886,0.025513927,0.000011937659,0.019858018,0.090816334,0.0005453471],"about_ca_topic_score_codex":0.6913801,"about_ca_topic_score_gemma":0.25362125,"teacher_disagreement_score":0.43775883,"about_ca_system_score_codex":0.0027301346,"about_ca_system_score_gemma":0.0013552677,"threshold_uncertainty_score":0.7599982},"labels":[],"label_agreement":null},{"id":"W4220883998","doi":"10.1007/s40487-022-00193-5","title":"Stapler-Assisted Pharyngeal Closure After Total Laryngectomy: A Systematic Review and Meta-Analysis","year":2022,"lang":"en","type":"review","venue":"Oncology and Therapy","topic":"Reconstructive Surgery and Microvascular Techniques","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Laryngectomy; Closure (psychology); Medicine; Meta-analysis; Surgery; Larynx; Internal medicine; Political science","score_opus":0.09282302367174915,"score_gpt":0.37923829548651233,"score_spread":0.2864152718147632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220883998","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003777272,0.9953689,0.0000061876513,0.00014613367,0.00006264331,0.0037328436,0.00014589485,0.00007120828,0.0004284193],"genre_scores_gemma":[0.00001858081,0.993787,0.0001699469,0.0013672556,0.000036035617,0.003308562,0.00021530782,0.000045573448,0.0010517363],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99611807,0.0018580923,0.0009293228,0.00065757765,0.000177359,0.00025957235],"domain_scores_gemma":[0.9981787,0.00046421346,0.0005687166,0.0005910554,0.000060233964,0.0001370448],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014186783,0.00055898324,0.012045029,0.00039913773,0.00012175875,0.00002050232,0.0001039235,0.00040301695,0.003570068],"category_scores_gemma":[0.000046895824,0.00034254437,0.003816337,0.00061306055,0.0001896743,0.000064886684,0.00008325947,0.00069307076,0.000005078329],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055716984,0.00017167984,0.0000131828565,0.4681302,0.39649004,0.0003504119,0.00003882494,8.689437e-10,4.443043e-7,0.000024893512,0.00021281955,0.1345118],"study_design_scores_gemma":[0.00019651461,0.0002561293,0.000009118723,0.003180491,0.52479714,0.0021314395,0.000006031326,3.4073267e-8,4.8680806e-7,0.000009273979,0.4692236,0.00018976883],"about_ca_topic_score_codex":0.00001048296,"about_ca_topic_score_gemma":0.000006379191,"teacher_disagreement_score":0.46901077,"about_ca_system_score_codex":0.00009940508,"about_ca_system_score_gemma":0.00027258912,"threshold_uncertainty_score":0.99990267},"labels":[],"label_agreement":null},{"id":"W4282542898","doi":"10.1007/s40487-022-00200-9","title":"Patient, Family Member and Physician Perspectives and Experiences with AML Treatment Decision-Making","year":2022,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Pfizer (Canada)","funders":"Pfizer Canada; Astellas Pharma; Flatiron Health; Springworks Therapeutics; Agios Pharmaceuticals; Jazz Pharmaceuticals; Celgene; AstraZeneca; National Institute of Nursing Research; Daiichi-Sankyo; Amgen; Pfizer; National Institutes of Health; Helsinn","keywords":"Medicine; Qualitative research; Quality of life (healthcare); Family medicine; Stakeholder; Perspective (graphical); Intensive care medicine; Nursing; Public relations","score_opus":0.023188599716836088,"score_gpt":0.3436971896524644,"score_spread":0.3205085899356283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282542898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987773,0.00799548,0.0000132719815,0.00060555723,0.000028881592,0.00030859394,0.000003122903,0.000014502219,0.0032576066],"genre_scores_gemma":[0.9956249,0.0025698706,0.0005752099,0.00087172096,0.000041986554,0.00019138995,0.0000016067119,0.000010348155,0.00011297227],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.99929607,0.00008616774,0.00007342159,0.0002636578,0.00012625057,0.00015442018],"domain_scores_gemma":[0.99954987,0.00022791426,0.000035854366,0.00009685342,0.000026533426,0.00006300267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008121428,0.00010280142,0.00021393721,0.00006468326,0.00032351952,0.000012025764,0.000026692682,0.0000351095,0.00010841862],"category_scores_gemma":[0.0000070754027,0.00006565374,0.000015688918,0.0000940818,0.0002937046,0.00004686212,0.000048859758,0.00013259944,5.8252476e-7],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032778827,0.00033836637,0.00616248,0.0000029857968,0.00016136093,0.00021292455,0.12898007,8.6471584e-7,0.001075382,0.00025011075,0.00020777993,0.85932976],"study_design_scores_gemma":[0.010598479,0.033509687,0.03947679,0.000041195413,0.000056901194,0.00071908854,0.8274046,0.00029351196,0.00056373276,0.00062308036,0.08643154,0.00028139492],"about_ca_topic_score_codex":0.00003824236,"about_ca_topic_score_gemma":0.000011177994,"teacher_disagreement_score":0.85904837,"about_ca_system_score_codex":0.00017249248,"about_ca_system_score_gemma":0.00013596963,"threshold_uncertainty_score":0.26772818},"labels":[],"label_agreement":null},{"id":"W4324129452","doi":"10.1007/s40487-023-00224-9","title":"Immune Checkpoint Inhibitors in Breast Cancer: A Narrative Review","year":2023,"lang":"en","type":"review","venue":"Oncology and Therapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Breast cancer; Malignancy; Adverse effect; Cancer; Oncology; Narrative review; Adjuvant; Internal medicine; Metastatic breast cancer; Immune system; Intensive care medicine; Immunology","score_opus":0.054315171648327346,"score_gpt":0.4046859411102719,"score_spread":0.35037076946194456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324129452","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000071667266,0.9923359,9.2175014e-8,0.004442444,0.00051617756,0.0019440993,0.000049979422,0.000055089957,0.0005845239],"genre_scores_gemma":[0.0000043369314,0.9963166,0.000008885898,0.001385426,0.00028520598,0.00091708876,0.00007507325,0.00006065114,0.0009467118],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978399,0.00031339342,0.0009516603,0.00044988535,0.00013172036,0.00031339427],"domain_scores_gemma":[0.9989923,0.00015182406,0.000436786,0.00028555383,0.00004929453,0.00008420055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008467906,0.0004182768,0.0027822074,0.00023408902,0.000074929456,0.000008380481,0.00011986234,0.00052541663,0.0004712477],"category_scores_gemma":[0.000014415133,0.00028396887,0.0005385563,0.0007198178,0.0002226761,0.000039615887,0.00003848706,0.00067346863,0.000028959294],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047856919,0.0001299759,0.000026088195,0.017131798,0.0006846821,0.00011111215,0.00037473798,3.2241623e-9,0.00001315978,0.000008086133,0.001958934,0.9790829],"study_design_scores_gemma":[0.0019137701,0.0003699225,0.0002377591,0.103891276,0.0002787264,0.0005283861,0.00007421268,1.6949747e-7,0.0000021757778,0.000016859824,0.892444,0.00024274107],"about_ca_topic_score_codex":0.00038123713,"about_ca_topic_score_gemma":0.00012403943,"teacher_disagreement_score":0.9788401,"about_ca_system_score_codex":0.00043089283,"about_ca_system_score_gemma":0.0011456934,"threshold_uncertainty_score":0.99996126},"labels":[],"label_agreement":null},{"id":"W4389454730","doi":"10.1007/s40487-023-00253-4","title":"Experiences and Support Needs of Caregivers of Patients with Higher-Risk Myelodysplastic Syndrome via Online Bulletin Board in the USA, Canada and UK","year":2023,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novartis Pharma; Novartis","keywords":"Myelodysplastic syndromes; Medicine; Family medicine; Disease; Gerontology; Internal medicine","score_opus":0.01175460647217719,"score_gpt":0.26545001392252043,"score_spread":0.25369540745034325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389454730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853635,0.00015390344,9.162918e-7,0.0008661015,0.00004523117,0.00025232695,0.000027899721,0.0000031803309,0.000114079914],"genre_scores_gemma":[0.99830234,0.0011460206,0.000038082282,0.0002127684,0.000010716857,0.000021203592,0.00002040481,0.0000065922477,0.00024186677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992691,0.00009682882,0.00015183196,0.00012282425,0.00018826932,0.00017111817],"domain_scores_gemma":[0.9993375,0.0003629058,0.000077902725,0.00010628206,0.00005268363,0.00006275062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019130799,0.00009148506,0.00028758292,0.000114832175,0.000046383597,0.0000024933222,0.000069226015,0.000074309544,0.00017812371],"category_scores_gemma":[0.000021818232,0.00005417946,0.000009876463,0.00024608328,0.00042759348,0.000015000443,0.000028812141,0.00017076083,5.015857e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011612674,0.00008637414,0.981477,0.000035746758,0.00008076152,0.00017431988,0.009399338,0.0000013496361,0.000099268014,0.000017963584,0.0009539836,0.0065125776],"study_design_scores_gemma":[0.0038251416,0.0033531946,0.9798359,0.00001988197,0.000021655103,0.000040095692,0.0077526346,0.000010403617,0.00005161203,0.000010160831,0.0050211805,0.00005812531],"about_ca_topic_score_codex":0.101610616,"about_ca_topic_score_gemma":0.07783486,"teacher_disagreement_score":0.023775754,"about_ca_system_score_codex":0.000049304035,"about_ca_system_score_gemma":0.00034186817,"threshold_uncertainty_score":0.93899226},"labels":[],"label_agreement":null},{"id":"W4391881791","doi":"10.1007/s40487-024-00264-9","title":"Estimating Public Economic Gains from Early Breast Cancer and Curative Treatment: A Case Study in Human Epidermal Growth Factor Receptor (HER-2) Positive Targeted Therapies","year":2024,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"Wellcome Trust; F. Hoffmann-La Roche","keywords":"Breast cancer; Government revenue; Trastuzumab; Tax revenue; Economics; Revenue; Medicine; Cancer; Public economics; Internal medicine; Finance","score_opus":0.054900633213822006,"score_gpt":0.3224307863097,"score_spread":0.267530153095878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391881791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789471,0.015611472,0.000043768396,0.0020331368,0.00046996816,0.00051067484,0.0014989972,0.00004030114,0.0008446012],"genre_scores_gemma":[0.9960138,0.0029647294,0.0001357939,0.00027232958,0.0002949465,0.00016537838,0.000018445087,0.000034969205,0.00009956579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852437,0.000068900015,0.00048807508,0.0005834946,0.000013238857,0.00032193362],"domain_scores_gemma":[0.99933636,0.00021298244,0.00019802606,0.00012342878,0.000018829922,0.000110349305],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020764305,0.0002710892,0.00063009735,0.0002307278,0.00022316739,0.0001925835,0.00008049782,0.00017319115,0.000734613],"category_scores_gemma":[0.000009198638,0.00025855022,0.000065479566,0.000087625616,0.0001673663,0.00069824135,0.000028144475,0.00020171235,0.000028885239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021174637,0.00048053334,0.7345231,0.000009052354,0.00096560526,0.0004042708,0.047851346,0.000008161723,0.00009411975,0.019253435,0.00009396559,0.19610463],"study_design_scores_gemma":[0.0067690965,0.0030021395,0.9546164,0.00004885412,0.000027718375,0.00019688185,0.0035016055,0.0024909864,0.00008421881,0.023224236,0.005167118,0.00087071874],"about_ca_topic_score_codex":0.02744969,"about_ca_topic_score_gemma":0.0049568526,"teacher_disagreement_score":0.2200933,"about_ca_system_score_codex":0.0005188017,"about_ca_system_score_gemma":0.000117682976,"threshold_uncertainty_score":0.99998665},"labels":[],"label_agreement":null},{"id":"W4392795080","doi":"10.1007/s40487-024-00268-5","title":"Real-World Treatment Patterns and Survival Among Patients with Stage I–III, Non-Squamous, Non-Small Cell Lung Cancer Receiving Surgery as Primary Treatment","year":2024,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; AstraZeneca (Canada); Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; AstraZeneca Canada; GlaxoSmithKline; Amgen","keywords":"Medicine; Internal medicine; Population; Oncology; Stage (stratigraphy); Chemotherapy; Cancer; Lung cancer; Surgery","score_opus":0.014697322355602704,"score_gpt":0.2974800527551476,"score_spread":0.2827827303995449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392795080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885748,0.004139137,0.0000073814826,0.00057457306,0.00048696544,0.0013768167,0.00008497722,0.00006851313,0.004686862],"genre_scores_gemma":[0.9131094,0.08011572,0.000045401004,0.00024829735,0.00020070936,0.0007559132,0.00016228658,0.000058742142,0.005303478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844927,0.00008071352,0.00028071427,0.0006344506,0.00016252213,0.00039230962],"domain_scores_gemma":[0.9988246,0.0005351684,0.0001059999,0.00025584825,0.00004826598,0.0002301377],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013411416,0.00040797627,0.00076686754,0.00016699165,0.00015393445,0.000051586656,0.000035027093,0.00014032017,0.00020910574],"category_scores_gemma":[0.0000013195454,0.00025252762,0.00011616569,0.00014078015,0.000099023484,0.0000926948,0.000020821726,0.00012504114,0.000003879121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096000754,0.0014114475,0.8859293,0.00019110536,0.00092497683,0.00050487125,0.001601324,0.0000026227715,0.000027296808,0.000007757124,0.00026893726,0.10817036],"study_design_scores_gemma":[0.008730102,0.004626852,0.9753984,0.0004366133,0.00055611925,0.0000067338183,0.00009447091,0.000052189313,0.0011354068,0.000003929404,0.008696405,0.00026273166],"about_ca_topic_score_codex":0.01900398,"about_ca_topic_score_gemma":0.013035931,"teacher_disagreement_score":0.10790763,"about_ca_system_score_codex":0.001535688,"about_ca_system_score_gemma":0.0005974876,"threshold_uncertainty_score":0.99999267},"labels":[],"label_agreement":null},{"id":"W4394843319","doi":"10.1007/s40487-024-00276-5","title":"Correction: Real-World Treatment Patterns and Survival Among Patients with Stage I–III, Non-Squamous, Non-Small Cell Lung Cancer Receiving Surgery as Primary Treatment","year":2024,"lang":"en","type":"erratum","venue":"Oncology and Therapy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; AstraZeneca (Canada); Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Primary treatment; Medicine; Stage (stratigraphy); Squamous cell cancer; Lung cancer; Cancer treatment; Oncology; Surgery; Internal medicine; Cancer; Biology","score_opus":0.012918693792509484,"score_gpt":0.3077022416866206,"score_spread":0.2947835478941111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394843319","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88110065,0.008740097,0.000012580669,0.00046091102,0.021843107,0.0030046506,0.00044559964,0.00012664289,0.08426575],"genre_scores_gemma":[0.18211082,0.14970829,0.000035578338,0.0003783191,0.001493783,0.0015251271,0.0030507783,0.00018134252,0.66151595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978107,0.00011028568,0.00043290685,0.0009249499,0.00023977864,0.00048134633],"domain_scores_gemma":[0.9984948,0.00040017327,0.0003286864,0.00036993934,0.00012535145,0.0002810751],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000116536896,0.000734517,0.0013500854,0.00033742478,0.00029611588,0.00006955852,0.00005333732,0.00048228767,0.00029635156],"category_scores_gemma":[0.000002981499,0.00048497718,0.00018710177,0.00021101674,0.00014601705,0.00008998477,0.000030794996,0.00046497272,0.000005772717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012906067,0.0015748058,0.84456176,0.0003811558,0.0026758958,0.0005023631,0.0025445821,0.000003314163,0.000003605804,0.000002034571,0.06784842,0.07861146],"study_design_scores_gemma":[0.009102915,0.005455773,0.74094224,0.0010113223,0.0023719962,0.000016055445,0.00024332516,0.00005481945,0.000055441815,0.0000035660617,0.24022682,0.0005157308],"about_ca_topic_score_codex":0.03270289,"about_ca_topic_score_gemma":0.037474543,"teacher_disagreement_score":0.69898987,"about_ca_system_score_codex":0.0024733057,"about_ca_system_score_gemma":0.0023152707,"threshold_uncertainty_score":0.9997602},"labels":[],"label_agreement":null},{"id":"W4395464285","doi":"10.1007/s40487-024-00272-9","title":"Identification of a Patient Suitable for CAR-T Cell Therapy in the Outpatient Setting: A Vodcast and Case Example","year":2024,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Hospital","funders":"","keywords":"Medicine; Referral; Chimeric antigen receptor; CAR T-cell therapy; CD19; Patient education; Cytokine release syndrome; Intensive care medicine; Medical emergency; Immunotherapy; Internal medicine; Cancer; Family medicine; Immunology; Antigen","score_opus":0.046091410346501216,"score_gpt":0.3533299062937665,"score_spread":0.30723849594726527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395464285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98668087,0.009939328,0.00005649327,0.001172682,0.000117908196,0.0015466862,0.000025163352,0.0000145724125,0.00044630576],"genre_scores_gemma":[0.9946289,0.0038921516,0.0000705713,0.00036296208,0.00005995692,0.00030173353,0.00001762104,0.000018885532,0.00064721075],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989072,0.00019503977,0.000288098,0.00026516354,0.00013424811,0.00021023733],"domain_scores_gemma":[0.99891835,0.000693556,0.00006126109,0.00020761475,0.00007197629,0.000047265636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010898677,0.00011163252,0.0002276834,0.0001323418,0.00008338863,0.000030602525,0.000052844443,0.00012616889,0.000100958416],"category_scores_gemma":[0.000021313193,0.00007237142,0.000054942884,0.00017617803,0.00012881926,0.0000451068,0.000015907932,0.00021025958,0.0000012645089],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018759109,0.00072316447,0.0038104167,0.00017040149,0.00010171235,0.00031875278,0.038066275,0.0000018701593,0.16699217,0.0005356178,0.0005931816,0.7868105],"study_design_scores_gemma":[0.018542169,0.03085217,0.00949454,0.00016600995,0.00011277606,0.0037365407,0.021265656,0.0042097536,0.14383921,0.0036806744,0.7635942,0.0005063023],"about_ca_topic_score_codex":0.00035962762,"about_ca_topic_score_gemma":0.00010683803,"teacher_disagreement_score":0.78630424,"about_ca_system_score_codex":0.000050954794,"about_ca_system_score_gemma":0.00012012983,"threshold_uncertainty_score":0.29512206},"labels":[],"label_agreement":null},{"id":"W4401113520","doi":"10.1007/s40487-024-00292-5","title":"Treatment Patterns and Resource Use After Osimertinib Discontinuation in Patients with EGFR + Metastatic NSCLC","year":2024,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Osimertinib; Medicine; Discontinuation; Oncology; Internal medicine; Lung cancer; Tolerability; Erlotinib; Regimen; Epidermal growth factor receptor; Cancer; Adverse effect","score_opus":0.016297307568909986,"score_gpt":0.3246357236851056,"score_spread":0.3083384161161956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401113520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964259,0.0015669091,0.000033267723,0.0012046334,0.0000341119,0.00046501379,0.000022297856,0.000015643414,0.0002322114],"genre_scores_gemma":[0.9981723,0.0005302234,0.00014678041,0.00032730316,0.000017969482,0.00014997655,0.00006687166,0.00001098536,0.00057762396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995641,0.00004025274,0.00009165311,0.00016558394,0.000047128597,0.00009126844],"domain_scores_gemma":[0.99978554,0.0000774019,0.000017971113,0.0000656331,0.000012059534,0.00004136528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000029515892,0.000088504145,0.00014661092,0.000062413426,0.000026381014,0.000021598114,0.000007277794,0.000030210807,0.000041141087],"category_scores_gemma":[0.0000023194932,0.000050479022,0.00001516656,0.000050805527,0.00003733835,0.00008441574,0.0000037092814,0.00004375207,0.0000019408992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011108299,0.0004665446,0.6796559,0.000009793305,0.0003174231,0.000082983475,0.0024796817,4.2348722e-7,0.000007476777,0.00007240528,0.00001825247,0.31577826],"study_design_scores_gemma":[0.006883655,0.003745751,0.9650106,0.00008385627,0.00022484957,0.000010224185,0.00010678814,0.000034947763,0.00003200518,0.000035244855,0.023771575,0.000060527098],"about_ca_topic_score_codex":0.00015753036,"about_ca_topic_score_gemma":0.00019327555,"teacher_disagreement_score":0.31571773,"about_ca_system_score_codex":0.000083891544,"about_ca_system_score_gemma":0.00004867039,"threshold_uncertainty_score":0.20584749},"labels":[],"label_agreement":null},{"id":"W4406073812","doi":"10.1007/s40487-024-00323-1","title":"Aggressive Subtypes of Laryngeal Chondrosarcoma and their Clinical Behavior: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Oncology and Therapy","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Laryngectomy; Chondrosarcoma; Cricoid cartilage; Surgery; Adjuvant therapy; Larynx; General surgery; Internal medicine; Chemotherapy","score_opus":0.06825644552588343,"score_gpt":0.4429915277639929,"score_spread":0.3747350822381095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406073812","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045037645,0.99540424,1.9466925e-7,0.00011383237,0.0001488134,0.003457488,0.000058683647,0.000014865692,0.0003514924],"genre_scores_gemma":[0.000100630896,0.99800485,0.000029811725,0.0004416716,0.000040999163,0.0008612289,0.00007515267,0.000020072388,0.00042559137],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9977926,0.0006420736,0.0009808412,0.00035506245,0.000074669544,0.00015476365],"domain_scores_gemma":[0.9973125,0.0012127397,0.00094205653,0.00036748833,0.00006191143,0.00010333827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050726667,0.00033996196,0.005451201,0.000092136055,0.000047908583,0.0000052033815,0.00008845289,0.0003879626,0.000037294478],"category_scores_gemma":[0.00014461353,0.00018189165,0.00047683477,0.00012316454,0.00021924822,0.000018888326,0.0000494559,0.0003418774,0.0000052605155],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022448567,0.0005779805,0.001008714,0.44086465,0.0007410354,0.00017630936,0.000016739188,3.3266192e-11,3.5096313e-8,0.00007007044,0.00014837153,0.55637366],"study_design_scores_gemma":[0.0016751913,0.0019135762,0.00063900056,0.7923439,0.009245067,0.0010396536,0.000009311943,7.675147e-8,6.017748e-7,0.00003304065,0.19293971,0.00016082205],"about_ca_topic_score_codex":0.0000074660793,"about_ca_topic_score_gemma":0.0000065821555,"teacher_disagreement_score":0.5562128,"about_ca_system_score_codex":0.000031148276,"about_ca_system_score_gemma":0.00038932211,"threshold_uncertainty_score":0.7417326},"labels":[],"label_agreement":null},{"id":"W4408885282","doi":"10.1007/s40487-025-00328-4","title":"A US Survey Across Seven Early-Stage Cancers Assessing the Humanistic Burden of Recurrence on Patients and Caregivers","year":2025,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"Cancer survivorship and care","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); Heritage College","funders":"Merck","keywords":"Medicine; Quality of life (healthcare); Cancer; Stage (stratigraphy); Internal medicine; Disease; Oncology; Feeling; Nursing; Psychology","score_opus":0.03225054663697788,"score_gpt":0.3738300962716893,"score_spread":0.3415795496347114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408885282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954242,0.0011303825,0.000009555821,0.00029804613,0.00038661118,0.00020358473,0.000049167487,0.0000072969065,0.0024911505],"genre_scores_gemma":[0.99769276,0.0012444064,0.0000037274772,0.00047095906,0.000026583133,0.000012749043,0.000012403943,0.0000049360224,0.00053148705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935687,0.00015801725,0.00010727984,0.00016574933,0.00008172084,0.00013037547],"domain_scores_gemma":[0.99936837,0.00031402803,0.000067998604,0.00012636288,0.00009019671,0.000033048284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028188768,0.000086740474,0.00020973526,0.000027589713,0.00015156505,0.000015291806,0.000057783294,0.000084926985,0.000018050341],"category_scores_gemma":[0.00004130489,0.000058560756,0.000024568797,0.00010860771,0.00024955056,0.000027371334,0.000023735944,0.0001568029,3.570032e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011098852,0.00006690021,0.8022321,0.000063491105,0.00014899534,0.0000097417105,0.023108583,0.00000492399,0.00009894714,0.00025414326,0.00031108918,0.17259122],"study_design_scores_gemma":[0.002091251,0.00090828125,0.9709244,0.000100739846,0.000023212755,0.0000010900868,0.002904536,0.000016712387,0.00013920284,0.000061439016,0.022760855,0.00006829689],"about_ca_topic_score_codex":0.011361802,"about_ca_topic_score_gemma":0.0051839896,"teacher_disagreement_score":0.17252293,"about_ca_system_score_codex":0.00009274893,"about_ca_system_score_gemma":0.00018850123,"threshold_uncertainty_score":0.9952216},"labels":[],"label_agreement":null},{"id":"W4409538399","doi":"10.1007/s40487-025-00334-6","title":"On the Horizon: A Global Multidisciplinary Perspective on Delivering Emerging Therapies for Patients with BCG-Naïve High-Risk NMIBC","year":2025,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Daiichi Sankyo Europe; EMD Serono; EUSA Pharma; Astellas Pharma; Genentech; UroGen Pharma; Eisai; Ipsen; Mirati Therapeutics; Gilead Sciences; Merck KGaA; Advanced Accelerator Applications; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Multidisciplinary approach; Perspective (graphical); Medicine; Horizon; Intensive care medicine; Computer science; Sociology; Physics; Artificial intelligence; Astronomy; Social science","score_opus":0.005897211184523203,"score_gpt":0.262218595216976,"score_spread":0.2563213840324528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409538399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97525895,0.017896706,0.00018508223,0.0019704897,0.00071939704,0.00079311075,0.000045725865,0.000049702896,0.0030808598],"genre_scores_gemma":[0.99748415,0.0015832186,0.000029587325,0.00046136626,0.0000068129107,0.00017900563,0.000024106253,0.000011977327,0.00021980518],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986251,0.00038529633,0.00017560397,0.0003917647,0.000040442686,0.0003817641],"domain_scores_gemma":[0.9985415,0.0009297732,0.00011192749,0.00025632684,0.00015515857,0.0000053451845],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00038359908,0.00023136991,0.00028041165,0.00008707674,0.0015391678,0.000017023101,0.00022670694,0.00023698568,0.000056411773],"category_scores_gemma":[0.00006125368,0.00013818529,0.00007922911,0.00021107627,0.0005671561,0.00005192183,0.000052882653,0.00042010655,0.000020841317],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01431606,0.0025099905,0.00964764,0.000013972441,0.0017453752,0.0000031826596,0.009929627,0.00008975534,0.0016264183,0.47675195,0.00046515896,0.4829009],"study_design_scores_gemma":[0.0470002,0.0533543,0.49220493,0.0004397103,0.00030815814,0.00001320189,0.056027625,0.00007717231,0.004475039,0.2260311,0.11858665,0.0014819151],"about_ca_topic_score_codex":0.00024274892,"about_ca_topic_score_gemma":0.000023827593,"teacher_disagreement_score":0.4825573,"about_ca_system_score_codex":0.0001344423,"about_ca_system_score_gemma":0.00008639451,"threshold_uncertainty_score":0.9997607},"labels":[],"label_agreement":null},{"id":"W4411202089","doi":"10.1007/s40487-025-00350-6","title":"Impact of Tumor Response and Response Duration on Survival Among Participants Receiving Pembrolizumab Plus Chemotherapy as First-Line Therapy for Non-Small-Cell Lung Cancer","year":2025,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Pembrolizumab; Lung cancer; Medicine; Oncology; Chemotherapy; Complete response; Internal medicine; Duration (music); Cancer; Immunotherapy","score_opus":0.028651675311576492,"score_gpt":0.36962959291600705,"score_spread":0.3409779176044306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411202089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98989135,0.0046672714,0.00008558413,0.0030872093,0.00027926796,0.0017255227,0.000030915664,0.000034445067,0.00019842027],"genre_scores_gemma":[0.9770621,0.019781258,0.00007536931,0.0014214478,0.00009040084,0.00033320847,0.000009034534,0.000037762955,0.0011894141],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.998185,0.00038252582,0.0004787973,0.0004264516,0.00013010431,0.00039715416],"domain_scores_gemma":[0.99772274,0.0014496649,0.0002704995,0.00030095264,0.00014236929,0.00011374209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016012725,0.00030297547,0.0006731246,0.00024073993,0.0002285756,0.000024271685,0.00009712749,0.00024872166,0.0001432532],"category_scores_gemma":[0.00011823443,0.00022916829,0.00019366689,0.00026072378,0.00026421656,0.00007356053,0.000015212521,0.0002001995,4.8558655e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68179774,0.0005781352,0.096631944,0.00007843295,0.0008395981,0.000016515067,0.0028034612,0.000019963101,0.16839243,0.00001243206,0.0004050624,0.04842428],"study_design_scores_gemma":[0.047304932,0.013383323,0.891129,0.00031031217,0.00008173063,0.000014896946,0.00019796315,0.0012189226,0.04277011,0.00007276091,0.0032717672,0.00024424947],"about_ca_topic_score_codex":0.000487406,"about_ca_topic_score_gemma":0.00018861775,"teacher_disagreement_score":0.7944971,"about_ca_system_score_codex":0.00039718577,"about_ca_system_score_gemma":0.0012490718,"threshold_uncertainty_score":0.9345212},"labels":[],"label_agreement":null},{"id":"W4412629771","doi":"10.1007/s40487-025-00357-z","title":"The Health Impact of Using Anti-PD-1 Agents to Treat Early-Stage Cancer in Belgium","year":2025,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"Merck","keywords":"Stage (stratigraphy); Cancer; Medicine; Internal medicine; Biology","score_opus":0.04550332840947906,"score_gpt":0.4467312410999579,"score_spread":0.4012279126904788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412629771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842258,0.010304539,0.000013749225,0.0040724254,0.00018685433,0.00041557485,0.000017926777,0.0000066460652,0.0007564816],"genre_scores_gemma":[0.97631323,0.020825356,0.000029716482,0.0018332318,0.000030918007,0.000016689695,0.0000015054655,0.0000066439784,0.00094273454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993144,0.00009557099,0.00020309289,0.00013263518,0.00005370559,0.00020057986],"domain_scores_gemma":[0.9996455,0.000073268704,0.00006998942,0.0001395149,0.000024338853,0.000047429512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031754604,0.000090715526,0.00029625933,0.000100747886,0.00010470297,0.000006209523,0.00005544456,0.000076633645,0.00008231838],"category_scores_gemma":[0.000005369643,0.000054560227,0.00007272709,0.00026846092,0.00010161163,0.000021285514,0.000013033913,0.00009687622,3.8520577e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009949729,0.0002243113,0.5199478,0.000033632015,0.00031119797,0.000010840706,0.0017032215,0.000014880779,0.02216636,0.00007979133,0.00092213065,0.4446361],"study_design_scores_gemma":[0.0038289754,0.001600991,0.958703,0.00011045126,0.000011752758,0.000004563486,0.00014124297,0.00004379205,0.0017031287,0.0000350649,0.03375924,0.000057801524],"about_ca_topic_score_codex":0.0076779723,"about_ca_topic_score_gemma":0.00080271065,"teacher_disagreement_score":0.4445783,"about_ca_system_score_codex":0.00029282708,"about_ca_system_score_gemma":0.000595432,"threshold_uncertainty_score":0.99893},"labels":[],"label_agreement":null},{"id":"W4414120871","doi":"10.1007/s40487-025-00366-y","title":"A Practical Approach to Understanding Real-World Study Methodology in Cancer Research: A Vodcast","year":2025,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Pfizer","keywords":"Sample size determination; Research design; MEDLINE; Clinical Practice; Evidence-based medicine; Statistical analysis; Clinical trial; Statistical model","score_opus":0.8987679318139231,"score_gpt":0.6867908155549045,"score_spread":0.2119771162590186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414120871","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31065696,0.0002418073,0.49876392,0.016441766,0.0002445328,0.004206189,0.0000043957,0.0003035849,0.16913687],"genre_scores_gemma":[0.7867468,0.00090437423,0.20952336,0.00059351977,0.00004300161,0.0009976458,6.4131984e-7,0.000019458683,0.0011712167],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9971093,0.0018149422,0.00025944333,0.00035183664,0.00012067044,0.00034383536],"domain_scores_gemma":[0.9945526,0.005044349,0.000053640873,0.00023515952,0.000055081746,0.000059153557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040805903,0.00012251636,0.00040525384,0.00053844444,0.00012654415,0.000016492539,0.000129546,0.00015219656,0.00003329938],"category_scores_gemma":[0.00065432914,0.00010255766,0.000019427309,0.00078769226,0.00019063342,0.000073898074,0.000117756805,0.00061559974,0.0000013152289],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005872799,0.0011434254,0.004225088,0.000016203598,0.00006440797,0.00002805162,0.003967774,0.0000014516602,0.0005723051,0.9781987,0.0016481661,0.0095471265],"study_design_scores_gemma":[0.001038405,0.001048697,0.0014756995,0.000035570898,0.000012002179,0.00000581972,0.0070958463,0.000041820113,0.0004803241,0.9834377,0.0052102082,0.00011788235],"about_ca_topic_score_codex":0.00058382197,"about_ca_topic_score_gemma":0.0053422833,"teacher_disagreement_score":0.47608984,"about_ca_system_score_codex":0.0005592914,"about_ca_system_score_gemma":0.00025404448,"threshold_uncertainty_score":0.41821796},"labels":[],"label_agreement":null},{"id":"W4417359965","doi":"10.1007/s40487-025-00406-7","title":"Social Determinants of Health in Metastatic Breast Cancer Care: A Podcast Exploring Challenges and Opportunities in the United States and Canada","year":2025,"lang":"en","type":"article","venue":"Oncology and Therapy","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Pfizer","keywords":"Health care; Socioeconomic status; Health equity; Social determinants of health; Breast cancer; Ethnic group; Scope (computer science); Metastatic breast cancer; Scope of practice","score_opus":0.29897731773279473,"score_gpt":0.42306463785174125,"score_spread":0.12408732011894652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417359965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93520004,0.044897124,3.5918077e-7,0.019623226,0.000027455757,0.00013485091,0.000015317644,0.0000018394817,0.00009981691],"genre_scores_gemma":[0.8267734,0.17057894,0.000007803059,0.0025877564,0.000008923194,0.00003210048,0.0000035983555,0.0000021001806,0.0000053479303],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994214,0.00014583263,0.00015524527,0.00009412582,0.00005525363,0.00012814048],"domain_scores_gemma":[0.9997548,0.0001042312,0.000050910177,0.00003763152,0.000029036628,0.000023391265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002857182,0.000065335575,0.00026876148,0.000087186665,0.000059349957,0.0000033109127,0.000028096356,0.000025053927,0.000002281793],"category_scores_gemma":[0.0000045429833,0.000046028985,0.0000065040254,0.00006850693,0.00010134087,0.000036267582,0.000012342436,0.000093016155,4.15965e-9],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038739922,0.000029792756,0.10104255,0.00016097349,0.000031819283,0.00007547004,0.024832519,0.0000011514645,0.0000073779793,0.00060073845,0.000056072477,0.8727741],"study_design_scores_gemma":[0.0020732153,0.00035636956,0.88270265,0.00027453018,0.000015878273,0.00006189549,0.10684353,0.000038390463,0.0000143461075,0.00033263137,0.007229481,0.000057060042],"about_ca_topic_score_codex":0.49346694,"about_ca_topic_score_gemma":0.79772437,"teacher_disagreement_score":0.8727171,"about_ca_system_score_codex":0.00008291808,"about_ca_system_score_gemma":0.0006142487,"threshold_uncertainty_score":0.5099061},"labels":[],"label_agreement":null}]}